Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 11 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 2 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A

8(80.0%)

Phase 1

2(20.0%)

10Total

N/A(8)

Phase 1(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)

Showing 11 of 11 trials

NCT05273879Not ApplicableRecruiting

Necessity of Fusion Following Decompression Surgery in Patients With Single-level Lumbar Stenosis

Role: lead

NCT06059820Completed

Effectiveness of Conservative Treatment in Patients With Thoracic and Lumbar Fractures Without Neurological Deficit

Role: lead

NCT05484219Not ApplicableSuspended

Functional Navigation in Surgery of Cerebral Tumors and Vascular Malformations

Role: lead

NCT05484245Not ApplicableRecruiting

Sonography-guided Resection of Brain Mass Lesions

Role: lead

NCT05485038Not ApplicableSuspended

General Anesthesia Versus Awake Surgery in Resection of Gliomas and Metastases of Motor Areas

Role: lead

NCT05475522Not ApplicableSuspended

Intraoperative Sonographically Versus Fluorescence-guided Resection of Contrast-enhancing Gliomas and Brain Metastases

Role: lead

NCT05474573Not ApplicableRecruiting

Concurrent Fluorescence and Sonographically Guided Eradication of Contrast-enhancing Gliomas and Metastases

Role: lead

NCT05470374Not ApplicableSuspended

Intraoperative Sonographically Guided Resection of Non-enhancing Gliomas

Role: lead

NCT05477680Not ApplicableRecruiting

Intraoperative Brain Shift Calculation Study

Role: lead

NCT05693181Phase 1Unknown

Cord Blood Cells in Patients With Acute SCI

Role: lead

NCT04331405Phase 1Completed

Allogeneic Cord Blood Cells for Adults With Severe Acute Contusion Spinal Cord Injury

Role: lead

All 11 trials loaded